LONDON/FRANKFURT (Reuters) -Tariffs and Middle East turmoil are spooking European companies and the investors weighing their ...

BERLIN (Reuters) -German medical technology firm Brainlab on Tuesday became the latest IPO candidate in the region to put ...

The CEO of German medical technology firm Brainlab said on Tuesday that geopolitical uncertainties had prompted the decision ...

All websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

German medical technology firm Brainlab said on Monday it had set the price range for its initial public offering (IPO) at 80 ...

German medical technology company’s decision comes after car parts retailer Autodoc pushes back flotation plans ...

Advisors say that the Middle East and tariffs are scaring investors and European companies who are considering their initial public ...

Medical technology company Brainlab postponed its initial public offering in Frankfurt on Tuesday after some investors ...

Cirsa’s IPO comprises a €400m primary offering and a €53m secondary offering by LHMC Midco, a holding of Blackstone. Morgan ...

Germany's Brainlab postponed its planned initial public offering indefinitely, dealing another blow to Europe's IPO market.

German medical technology company Brainlab on Tuesday became the latest IPO candidate in the region to put listing plans on hold amid volatile stock markets over recent months. June 30, 2025 ...

Brainlab, the German medical technology company, set the price range for its forthcoming IPO at €80 to €100 a share on Monday ...